Eagle Capital Management Adds $75M in Danaher Corporation ($DHR)

Eagle Capital Management has boosted its stake in Danaher Corporation (NYSE: DHR) by 414,628 shares, according to its latest Form 13F filing with the SEC. This increase brings its total holdings to 6,575,159 shares, valued at approximately $1.19 billion as of the filing date.

What Changed in Eagle Capital Management's Danaher Position

Eagle Capital Management added 414,628 shares to its portfolio, increasing its stake in Danaher by about 6.73% from the previous quarter. The fund's total holdings now stand at 6,575,159 shares, a significant investment worth nearly $1.19 billion.

Other Institutional Activity in Danaher

In other institutional moves, BlackRock, Inc. trimmed its Danaher holdings by 396,733 shares, resulting in 51,640,619 shares valued at around $9.79 billion. Vanguard Capital Management LLC added a substantial 41,127,810 shares, bringing its total to the same amount, valued at $7.80 billion. State Street Corp grew its position by 212,847 shares to 27,894,181 shares, worth approximately $5.30 billion. Meanwhile, FMR LLC increased its stake by 3,027,600 shares, totaling 22,534,329 shares valued at about $4.27 billion. JPMorgan Chase & Co reduced its holdings by 4,667,877 shares, leaving it with 16,917,649 shares valued at $3.11 billion.

Danaher Stock Snapshot

Shares of Danaher Corporation (NYSE: DHR) traded at $180.79. The company boasts a market cap of $127.47 billion and a P/E ratio of 34.97. Danaher has a 52-week trading range between $160.93 and $242.80, with a 50-day moving average of $180.82 and a 200-day moving average of $204.87. The company maintains a current ratio of 1.87 and a quick ratio of 1.40, with a debt-to-equity ratio of 37.17.

Recent Earnings

Danaher reported revenues of $24.78 billion, reflecting a growth rate of 3.7%. The company's earnings per share (EPS) was $5.15, with a net margin of 14.89% and a return on equity (ROE) of 7.08%. The next earnings announcement is scheduled for April 21, 2026.

Dividend

Danaher offers an annual dividend rate of $1.60, yielding 0.89%. The dividend payout ratio stands at 26.36%, providing a steady income stream to shareholders.

Insider Buying and Selling at Danaher Corporation

Recent insider activity at Danaher shows several purchases on May 15, 2026. Charles Lamanna, Shane Sanders, Linda Filler, and Alan Spoon each bought 1,699 shares, with additional purchases by Sanders and Filler of 680 shares each. These transactions were not part of a pre-planned trading program.

Analysts Set New Price Targets

On June 11, 2026, Piper Sandler initiated coverage on Danaher with a hold rating and a $200 price target. HSBC maintained its buy rating with a $230 target on June 3, 2026, while Citigroup reinstated its buy rating with a $230 target on May 27, 2026. The consensus among 23 analysts is a strong buy, with a target mean price of $242.35.

About Danaher Corporation

Danaher Corporation, based in Washington, DC, designs and manufactures professional, medical, research, and industrial products. The company operates through three main segments: Biotechnology, Life Sciences, and Diagnostics. With a workforce of 58,000 employees, Danaher serves markets in the United States, China, and internationally under various brand names such as Beckman Coulter and Leica Microsystems. The company's CEO is Mr. Rainer M. Blair.

Bottom Line

Eagle Capital Management's recent increase in its Danaher stake underscores the fund's confidence in the company's long-term prospects. While the 13F filing reflects past positions, it's a key tool for investors tracking institutional activity. With active insider buying and favorable analyst ratings, Danaher remains a closely watched stock in the healthcare sector.